The Role of VHL in the Development of Von Hippel-Lindau Disease and Erythrocytosis

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2022 Feb 25

PMID 35205407

Authors

Petra Hudler

Mojca Urbancic

Affiliations

Soon will be listed here.

Abstract

Von Hippel-Lindau disease (VHL disease or VHL syndrome) is a familial multisystem neoplastic syndrome stemming from germline disease-associated variants of the tumor suppressor gene on chromosome 3. VHL is involved, through the EPO-VHL-HIF signaling axis, in oxygen sensing and adaptive response to hypoxia, as well as in numerous HIF-independent pathways. The diverse roles of VHL confirm its implication in several crucial cellular processes. VHL variations have been associated with the development of VHL disease and erythrocytosis. The association between genotypes and phenotypes still remains ambiguous for the majority of mutations. It appears that there is a distinction between erythrocytosis-causing VHL variations and VHL variations causing VHL disease with tumor development. Understanding the pathogenic effects of variants might better predict the prognosis and optimize management of the patient.

Citing Articles

Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes.

Lauricella E, Chaoul N, DAngelo G, Giglio A, Cafiero C, Porta C Curr Treat Options Oncol. 2025; 26(1):55-71.

PMID: 39821711 DOI: 10.1007/s11864-024-01288-z.

Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans.

Hwang S, Kang S, Kim J, Kim S PLoS One. 2024; 19(10):e0311665.

PMID: 39374255 PMC: 11458008. DOI: 10.1371/journal.pone.0311665.

Familial and early recurrent pheochromocytoma in a child with a novel in-frame duplication variant of .

Suzuki Y, Iemura R, Sutani A, Mizuno Y, Adachi E, Ushiama M Clin Pediatr Endocrinol. 2024; 33(4):229-237.

PMID: 39359666 PMC: 11442702. DOI: 10.1297/cpe.2024-0020.

Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF.

Sui X, Ma X, Hou Y, Cao S, Wang Z, Jia L Cell Biol Toxicol. 2024; 40(1):24.

PMID: 38653919 PMC: 11039524. DOI: 10.1007/s10565-024-09864-7.

Predictors of Progression in a Series of 81 Adult Patients Surgically Managed for an Intracranial Hemangioblastoma: Implications for the Postoperative Follow-Up.

Garrido E, Ngoc H, Guyotat J, Pelissou-Guyotat I, Jacquesson T, Delabar V Cancers (Basel). 2024; 16(7).

PMID: 38610939 PMC: 11010926. DOI: 10.3390/cancers16071261.

References

Couve S, Ladroue C, Laine E, Mahtouk K, Guegan J, Gad S . Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis. Cancer Res. 2014; 74(22):6554-64. PMC: 5555745. DOI: 10.1158/0008-5472.CAN-14-1161. View

Wittstrom E, Nordling M, Andreasson S . Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease. Ophthalmic Genet. 2014; 35(2):91-106. DOI: 10.3109/13816810.2014.886265. View

Roe J, Kim H, Lee S, Kim S, Cho E, Youn H . p53 stabilization and transactivation by a von Hippel-Lindau protein. Mol Cell. 2006; 22(3):395-405. DOI: 10.1016/j.molcel.2006.04.006. View

Gimenez-Roqueplo A, Dahia P, Robledo M . An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012; 44(5):328-33. DOI: 10.1055/s-0031-1301302. View

Choi H, Kim K, Hong N, Shin S, Choi J, Kang S . Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population. Endocrinol Metab (Seoul). 2021; 35(4):858-872. PMC: 7803615. DOI: 10.3803/EnM.2020.683. View

Hsu T, Adereth Y, Kose N, Dammai V . Endocytic function of von Hippel-Lindau tumor suppressor protein regulates surface localization of fibroblast growth factor receptor 1 and cell motility. J Biol Chem. 2006; 281(17):12069-80. PMC: 2367321. DOI: 10.1074/jbc.M511621200. View

Knauth K, Bex C, Jemth P, Buchberger A . Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions. Oncogene. 2005; 25(3):370-7. DOI: 10.1038/sj.onc.1209062. View

Mettu P, Agron E, Samtani S, Chew E, Wong W . Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype. Invest Ophthalmol Vis Sci. 2010; 51(9):4464-70. PMC: 2941163. DOI: 10.1167/iovs.10-5223. View

Wong W, Agron E, Coleman H, Reed G, Csaky K, Peterson J . Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis. Arch Ophthalmol. 2007; 125(2):239-45. PMC: 3019103. DOI: 10.1001/archopht.125.2.239. View

10.

Kong L, Yin H, Yuan L . Centrosomal MCM7 strengthens the Cep68-VHL interaction and excessive MCM7 leads to centrosome splitting resulting from increase in Cep68 ubiquitination and proteasomal degradation. Biochem Biophys Res Commun. 2017; 489(4):497-502. DOI: 10.1016/j.bbrc.2017.05.180. View

11.

Krieg M, Marti H, Plate K . Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood. 1998; 92(9):3388-93. View

12.

Percy M, McMullin M, Jowitt S, Potter M, Treacy M, Watson W . Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood. 2003; 102(3):1097-9. DOI: 10.1182/blood-2002-10-3246. View

13.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

14.

Tsoli M, Daskalakis K, Kassi E, Kaltsas G, Tsolakis A . A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors. Biology (Basel). 2021; 10(7). PMC: 8301201. DOI: 10.3390/biology10070580. View

15.

Dengler V, Galbraith M, Espinosa J . Transcriptional regulation by hypoxia inducible factors. Crit Rev Biochem Mol Biol. 2013; 49(1):1-15. PMC: 4342852. DOI: 10.3109/10409238.2013.838205. View

16.

Tate J, Bamford S, Jubb H, Sondka Z, Beare D, Bindal N . COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2018; 47(D1):D941-D947. PMC: 6323903. DOI: 10.1093/nar/gky1015. View

17.

Zeng L, Bai M, Mittal A, El-Jouni W, Zhou J, Cohen D . Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma. Cancer Res. 2013; 73(17):5371-80. PMC: 3766477. DOI: 10.1158/0008-5472.CAN-12-4707. View

18.

Ang S, Chen H, Hirota K, Gordeuk V, Jelinek J, Guan Y . Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet. 2002; 32(4):614-21. DOI: 10.1038/ng1019. View

19.

Ong K, Woodward E, Killick P, Lim C, MacDonald F, Maher E . Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat. 2006; 28(2):143-9. DOI: 10.1002/humu.20385. View

20.

Yang H, Joe S, Kim J, Park S, Ko H . Delayed choroidal and retinal blood flow in polycythaemia vera patients with transient ocular blindness: a preliminary study with fluorescein angiography. Br J Haematol. 2013; 161(5):745-747. DOI: 10.1111/bjh.12290. View